Introduction The global prevalence of multiple sclerosis (MS) has increased in recent decades. However, there is a need for updated prevalence data for Spain. Objective To analyze the prevalence of MS in Spain using data […]
Introduction Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder consisting in cerebrovascular dysregulation with acute neurological symptoms, including headache. However, there is a paucity of data that point to headache as a sequela of […]
Background Desminopathies are a clinically heterogeneous group of myopathies, with common histological findings in muscle biopsy. Clinically, they usually present with distal and/or proximal muscle weakness often associated with cardiomyopathy. We present 8 patients from […]
Introduction Cognitive impairment is a typical sequel and a solid long-term disability predictor that can be screened at early stages post-stroke. However, most routinely used cognitive screening tools were designed to detect dementia, which differs […]
Antecedentes Las alteraciones cognitivas son uno de los síntomas más comunes, insidiosos e incapacitantes de síndrome post-COVID-19 (PC-19), las cuales se han correlacionado con daño en diferentes estructuras cerebrales. Objetivo Describir alteraciones cognitivas PC-19 e […]
Introducción La Guía para el manejo del dolor en neurorrehabilitación del daño cerebral sobrevenido (DCS) de personas adultas de la Sociedad Española de Neurorrehabilitación (SENR) está basada en la revisión y análisis de la bibliografía […]
Introducción El paciente oncológico puede requerir la valoración por el neurólogo durante el ingreso hospitalario. El objetivo de nuestro estudio es conocer la frecuencia y las características de las interconsultas hospitalarias (ICh) solicitadas al servicio […]
Introduction Despite the wealth of evidence suggesting a protective role of lifestyle factors on Huntington’s disease (HD) onset and progression, their association with mortality has not been extensively studied. The aim of this study was […]
Introducción La adherencia es un factor modificable de respuesta a los tratamientos modificadores de la enfermedad en los pacientes con esclerosis múltiple (EM). Nuestro objetivo es valorar los factores de riesgo asociados a una inadecuada […]